Results 161 to 170 of about 289,419 (268)
Impact of Varied Recycled Aggregate Inclusions on Mechanical Properties and Damage Evolution Based on Multiphase Inclusion Theory. [PDF]
Ma Y, Chen T, Gao X, Jin C, Liu Q.
europepmc +1 more source
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
Research on damage evolution mechanism of sandstones with different lithologies under freeze-thaw cyclic loads. [PDF]
Li J, Wang W, Yao H, Yan J, Pei Z.
europepmc +1 more source
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu +3 more
wiley +1 more source
Influence of wave impedance of backfill medium on explosive stress wave propagation and rock mass damage evolution. [PDF]
Wang H, Liu C, Zhang X, Qiu H.
europepmc +1 more source
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
Investigating Surface Morphology and Subsurface Damage Evolution in Nanoscratching of Single-Crystal 4H-SiC. [PDF]
Xi J, Ban X, Hui Z, Ba W, Deng L, Qiu H.
europepmc +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Prediction of damage evolution in carbonate building stones subjected to simulated acid rain using M5P model. [PDF]
Bameri A, Ghasemi E, Nasiri Sarvi M.
europepmc +1 more source

